This announcement is a separate document:
三生製藥：( 1 ) 於二零二二年六月二十二日舉行之股東週年大會投票表決結果及( 2 ) 採納第二份經修訂及經重列組織章程大綱及細則
3SBIO: (1) POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 22 JUNE 2022 AND (2) ADOPTION OF THE SECOND AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.